Search details
1.
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.
Blood
; 143(24): 2490-2503, 2024 Jun 13.
Article
in English
| MEDLINE | ID: mdl-38493481
2.
Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis.
Nature
; 583(7817): 585-589, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32669716
3.
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.
Blood
; 141(17): 2127-2140, 2023 04 27.
Article
in English
| MEDLINE | ID: mdl-36758212
4.
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.
Blood Adv
; 8(9): 2312-2325, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38295283
5.
IL-1ß promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Blood Adv
; 8(5): 1234-1249, 2024 Mar 12.
Article
in English
| MEDLINE | ID: mdl-38207211
Results
1 -
5
de 5
1
Next >
>>